HRS-4508

N/A

Report date: 2026/03/24 20:00:35
NME

Base Information

Drug NameHRS-4508
Drug Alias NameHRS-4508
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine kinase inhibitors
TargetsSpleen tyrosine kinase
Therapy Area/IndicationsSolid tumoursLung Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Inactive CompaniesN/A
Active IndicationsSolid tumoursLung Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A